Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$10,552,523
+$1,442,302 QoQ
Shares Held
41,935
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
#898
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Whitener Capital Management, Inc. holds $31,660,073 across 7 Drug Manufacturers - General names. ABBV ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
41,935 | $10,552,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,121 | $6,633,950 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,420 | $5,836,470 | |
| 4 | LLY |
ELI LILLY & Co
|
2,960 | $3,550,313 | |
| 5 | AMGN |
Amgen Inc
|
5,665 | $2,051,409 | |
| 6 | PFE |
Pfizer Inc
|
82,959 | $1,997,652 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,214 | $1,037,756 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,552,523 | 41,935 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $9,110,221 | 41,888 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $9,261,156 | 40,532 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $9,330,598 | 40,298 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $7,215,235 | 38,871 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $8,040,539 | 38,376 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $6,799,868 | 38,266 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,495,748 | 37,957 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $6,538,342 | 38,120 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $6,437,963 | 35,354 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,441,771 | 35,115 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $5,182,965 | 34,771 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,574,218 | 33,951 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $5,235,304 | 32,850 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $5,216,770 | 32,280 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $4,326,661 | 32,238 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $4,462,010 | 29,133 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,454,620 | 27,479 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,485,737 | 25,744 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,532,895 | 23,481 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,794,711 | 24,811 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,543,819 | 23,506 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,515,989 | 23,481 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,017,635 | 23,035 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $2,189,904 | 22,305 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,695,532 | 22,254 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||